US-based AG1 unveils its “most significant innovation” with the first major upgrade of its all-in-one supplement powder mix in 15 years. The AG1 Next Gen blend, which includes upgraded probiotics and added vitamins and minerals, is only available on the North American market. The company says the formula is clinically shown to close common nutrient gaps and support gut health. The company shares scientific support from four randomized, placebo-controlled human clinical trials with the launch. Moreover, AG1 has committed over US$20 million to continued research.